• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Ron Ellis - Articles and news items

Merck logo
Merck logo

Exclusive worldwide agreement to develop and commercialize Phase III cancer candidate vintafolide (EC145)

Industry news, News / 16 April 2012 / Merck

Vintafolide is currently being evaluated in a Phase III clinical trial…

 

Webinar: SIFT-MS: A New Tool for Impurity Profiling in Pharmaceutical ProductsLEARN MORE
+ +